Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease

NCT02425111 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
101
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda